
Arcticzymes Technologies ASA
OSE:AZT

Arcticzymes Technologies ASA
Revenue
Arcticzymes Technologies ASA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Arcticzymes Technologies ASA
OSE:AZT
|
Revenue
kr104.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
12%
|
|
![]() |
Hofseth Biocare ASA
OSE:HBC
|
Revenue
kr257.4m
|
CAGR 3-Years
43%
|
CAGR 5-Years
31%
|
CAGR 10-Years
29%
|
|
B
|
Bergenbio ASA
OSE:BGBIO
|
Revenue
kr848k
|
CAGR 3-Years
3%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Revenue
kr4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
Revenue
$8.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
Revenue
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Arcticzymes Technologies ASA
Glance View
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

See Also
What is Arcticzymes Technologies ASA's Revenue?
Revenue
104.4m
NOK
Based on the financial report for Dec 31, 2024, Arcticzymes Technologies ASA's Revenue amounts to 104.4m NOK.
What is Arcticzymes Technologies ASA's Revenue growth rate?
Revenue CAGR 10Y
12%
Over the last year, the Revenue growth was -12%. The average annual Revenue growth rates for Arcticzymes Technologies ASA have been -7% over the past three years , 18% over the past five years , and 12% over the past ten years .